Lis Hasholt

2.5k total citations
86 papers, 1.6k citations indexed

About

Lis Hasholt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Lis Hasholt has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 41 papers in Cellular and Molecular Neuroscience and 28 papers in Physiology. Recurrent topics in Lis Hasholt's work include Genetic Neurodegenerative Diseases (34 papers), Mitochondrial Function and Pathology (26 papers) and Lysosomal Storage Disorders Research (23 papers). Lis Hasholt is often cited by papers focused on Genetic Neurodegenerative Diseases (34 papers), Mitochondrial Function and Pathology (26 papers) and Lysosomal Storage Disorders Research (23 papers). Lis Hasholt collaborates with scholars based in Denmark, Sweden and United States. Lis Hasholt's co-authors include Anne Nørremølle, Jørgen E. Nielsen, Kirsten Fenger, S. A. Sørensen, Sven Asger Sørensen, Ulla Feldt‐Rasmussen, Troels T. Nielsen, Hans Eiberg, Pernille Koefoed and Åse Krogh Rasmussen and has published in prestigious journals such as Brain, Biological Psychiatry and Pain.

In The Last Decade

Lis Hasholt

81 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lis Hasholt Denmark 24 835 823 412 409 152 86 1.6k
Ikuko Mizuta Japan 26 736 0.9× 762 0.9× 891 2.2× 334 0.8× 478 3.1× 98 2.0k
Maurizio De Fusco Italy 19 1.3k 1.6× 770 0.9× 351 0.9× 315 0.8× 455 3.0× 32 2.8k
Niccolò E. Mencacci United Kingdom 25 675 0.8× 798 1.0× 1.3k 3.1× 426 1.0× 245 1.6× 58 2.1k
Friedrich Metzger Switzerland 25 975 1.2× 747 0.9× 132 0.3× 437 1.1× 193 1.3× 61 1.9k
Patricia Kramer United States 15 848 1.0× 927 1.1× 853 2.1× 137 0.3× 270 1.8× 21 1.9k
Una‐Marie Sheerin United Kingdom 13 495 0.6× 567 0.7× 1.3k 3.1× 296 0.7× 370 2.4× 19 1.7k
Mariarita Santi United States 21 876 1.0× 1.0k 1.2× 320 0.8× 163 0.4× 154 1.0× 43 2.1k
Manu Sharma Germany 17 680 0.8× 552 0.7× 1.0k 2.5× 311 0.8× 380 2.5× 41 1.6k
C. Bergeron Canada 24 584 0.7× 472 0.6× 813 2.0× 788 1.9× 385 2.5× 44 2.1k
Bülent Elibol Türkiye 20 501 0.6× 755 0.9× 1.0k 2.5× 211 0.5× 330 2.2× 58 1.8k

Countries citing papers authored by Lis Hasholt

Since Specialization
Citations

This map shows the geographic impact of Lis Hasholt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lis Hasholt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lis Hasholt more than expected).

Fields of papers citing papers by Lis Hasholt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lis Hasholt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lis Hasholt. The network helps show where Lis Hasholt may publish in the future.

Co-authorship network of co-authors of Lis Hasholt

This figure shows the co-authorship network connecting the top 25 collaborators of Lis Hasholt. A scholar is included among the top collaborators of Lis Hasholt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lis Hasholt. Lis Hasholt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez, B., Hannah K. Shorrock, Mónica Báñez-Coronel, et al.. (2021). CCG•CGG interruptions in high‐penetrance SCA8 families increase RAN translation and protein toxicity. EMBO Molecular Medicine. 13(11). e14095–e14095. 16 indexed citations
2.
Rudenko, Olga, Louise J. Skov, Andreas Nygaard Madsen, et al.. (2019). Ghrelin‐mediated improvements in the metabolic phenotype in the R6/2 mouse model of Huntington's disease. Journal of Neuroendocrinology. 31(7). e12699–e12699. 11 indexed citations
3.
Reynolds, Regina H., Morten Dall, Jonas T. Treebak, et al.. (2017). Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model. Molecular and Cellular Neuroscience. 88. 118–129. 38 indexed citations
4.
Rasmussen, Mikkel A., Lena E. Hjermind, Lis Hasholt, et al.. (2015). Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT). Stem Cell Research. 16(1). 75–78. 8 indexed citations
5.
Nielsen, Troels T., Kirsten Svenstrup, Esben Budtz–Jørgensen, et al.. (2012). ATXN2 with intermediate-length CAG/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia. Journal of the Neurological Sciences. 321(1-2). 100–102. 7 indexed citations
6.
Havndrup, Ole, Michael Christiansen, Morten K. Jensen, et al.. (2010). Fabry Disease Mimicking Hypertrophic Cardiomyopathy: Genetic Screening Needed for Establishing the Diagnosis in Women. European Journal of Heart Failure. 12(6). 535–540. 63 indexed citations
7.
Josefsen, Knud, Thomas Seifert‐Held, Lis Hasholt, et al.. (2010). Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiology of Disease. 40(3). 656–662. 32 indexed citations
8.
9.
Møller, Anette Torvin, Flemming W. Bach, Ulla Feldt‐Rasmussen, et al.. (2009). Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain. 145(1). 237–245. 63 indexed citations
10.
Boesgaard, Trine Welløv, Troels T. Nielsen, Knud Josefsen, et al.. (2009). Huntington’s Disease Does Not Appear to Increase the Risk of Diabetes Mellitus. Journal of Neuroendocrinology. 21(9). 770–776. 34 indexed citations
11.
Møller, Anette Torvin, Flemming W. Bach, Ulla Feldt‐Rasmussen, et al.. (2009). Autonomic skin responses in females with Fabry disease. Journal of the Peripheral Nervous System. 14(3). 159–164. 20 indexed citations
12.
Lind-Thomsen, Allan, Mikkel W. Pedersen, Hanne Jarmer, et al.. (2008). GLI1 Is Involved in Cell Cycle Regulation and Proliferation of NT2 Embryonal Carcinoma Stem Cells. DNA and Cell Biology. 27(5). 251–256. 9 indexed citations
13.
Lindquist, Suzanne Granhøj, Lis Hasholt, Justyna M.C. Bahl, et al.. (2008). A novel presenilin 2 mutation (V393M) in early‐onset dementia with profound language impairment. European Journal of Neurology. 15(10). 1135–1139. 16 indexed citations
14.
Mersebach, Henriette, Per Johansson, Åse Krogh Rasmussen, et al.. (2007). Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genetics in Medicine. 9(12). 812–818. 40 indexed citations
15.
Nielsen, Jørgen E., Birger Johnsen, Pernille Koefoed, et al.. (2004). Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. European Journal of Neurology. 11(12). 817–824. 54 indexed citations
16.
Stub, C., Morten Møller, Kirsten Fenger, et al.. (2003). Molecular and behavioral analysis of the r6/1 huntington′s disease transgenic mouse. Neuroscience. 122(4). 1049–1057. 99 indexed citations
17.
Nellemann, Christine, Kathrine Abell, Anne Nørremølle, et al.. (2000). Inhibition of Huntingtin Synthesis by Antisense Oligodeoxynucleotides. Molecular and Cellular Neuroscience. 16(4). 313–323. 29 indexed citations
18.
Larsen, Lars Allan, Karen Grønskov, Bent Nørgaard‐Pedersen, et al.. (1997). High-throughput analysis of Fragile X (CGG) n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Human Genetics. 100(5-6). 564–568. 42 indexed citations
19.
Vanholder, Raymond, Kirsten Madsen, Marleen Praet, et al.. (1996). Novel Frameshift Mutation in a Heterozygous Woman with Fabry Disease and End-Stage Renal Failure. American Journal of Nephrology. 16(4). 352–357. 22 indexed citations
20.
Madsen, Kirsten, et al.. (1995). Two novel mutations (L32P) and (G85N) among five different missense mutations in six Danish families with Fabry's disease. Human Mutation. 5(3). 277–278. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ikuko Mizuta Breakdown of academic impact, for papers by Maurizio De Fusco Breakdown of academic impact, for papers by Niccolò E. Mencacci Breakdown of academic impact, for papers by Friedrich Metzger Breakdown of academic impact, for papers by Patricia Kramer Breakdown of academic impact, for papers by Una‐Marie Sheerin Breakdown of academic impact, for papers by Mariarita Santi Breakdown of academic impact, for papers by Manu Sharma Breakdown of academic impact, for papers by C. Bergeron Breakdown of academic impact, for papers by Bülent Elibol
Rankless by CCL
2026